Uptravi and Risperdal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Uptravi (selexipag) and Risperdal (risperidone). Common drug interactions include nausea among females and acute right ventricular failure among males.

The phase IV clinical study analyzes what interactions people have when they take Uptravi and Risperdal. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Uptravi?

Uptravi has active ingredients of selexipag. eHealthMe is studying from 26,576 Uptravi users. Check the latest studies of Uptravi.

What is Risperdal?

Risperdal has active ingredients of risperidone. It is often used in bipolar disorder. eHealthMe is studying from 127,729 Risperdal users. Check the latest studies of Risperdal.

On Jul, 05, 2026

15 people who take Uptravi and Risperdal together, and have interactions are studied.

Uptravi and Risperdal drug interactions.

What are the common drug interactions of Uptravi and Risperdal, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Malaise (a feeling of general discomfort or uneasiness)
Headache (pain in head)
Myalgia (muscle pain)
Brain natriuretic peptide increased
Infusion site induration
Infusion site infection
Infusion site pain
Infusion site swelling

male:

Acute right ventricular failure (acute heart attack)
Cough
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Hypokalaemia (low potassium)
Pneumonia
Pneumonia influenzal (the flu with pneumonia)
Pyrexia (fever)
Respiratory tract haemorrhage (respiratory tract bleeding)
Respiratory tract infection
Right ventricular failure (right half of the heart fails to work)

What are the common drug interactions of Uptravi and Risperdal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Brain natriuretic peptide increased
Infusion site induration
Infusion site infection
Infusion site pain
Infusion site swelling
Pulmonary arterial pressure increased
Injection site induration

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Blood potassium decreased
Constipation
Disease recurrence
Hypoaesthesia (reduced sense of touch or sensation)
Nausea (feeling of having an urge to vomit)
Pneumonia
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Pulmonary congestion (congestion in the lungs)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Weight decreased

60+:

Headache (pain in head)
Myalgia (muscle pain)
Pyrexia (fever)
Respiratory tract haemorrhage (respiratory tract bleeding)
Respiratory tract infection
Right ventricular failure (right half of the heart fails to work)
Toothache (tooth pain)
Acute right ventricular failure (acute heart attack)
Arthralgia (joint pain)
Cough

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 12 people, 80.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 20.00%
Type 2 Diabetes: 2 people, 13.33%
Right Ventricular Failure (right half of the heart fails to work): 2 people, 13.33%
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 2 people, 13.33%
Stable Angina (a constant chest pain): 1 person, 6.67%
Insomnia (sleeplessness): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Headache (pain in head): 1 person, 6.67%
Gastric Ulcer (stomach ulcer): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Uptravi and Risperdal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously